Cadence Pharmaceuticals, Inc. (CADX) Tops Q2 EPS by 8c, Revenue Falls Inline
Tweet
Share
E-mailGet Alerts CADX Hot Sheet
Price: $13.98 --0%
Financial Fact:
Interest expense: -1.13M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Interest expense: -1.13M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) reported Q2 EPS of ($0.30), $0.08 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $1.62 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- KULR Technology Group (KULR) Misses Q2 EPS by 39c
- Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
